Version: 1.0.0 | Published: 7 Oct 2026 | Updated: 0 days ago
Documentation
Description:
Provide proof of concept that quantitative haemodynamic MRI markers can stratify the efficacy of carvedilol to lower clinically significant portal hypertension in patients with cirrhosis.
Coverage
Spatial:
Nottinghamshire
Typical Age Range:
18-80
Follow Up:
1 - 10 Years
Pathway:
Secondary care
Provenance
Origin
Purposes:
Study
Sources:
Paper-based
Collection Situations:
Secondary care - Outpatients
Temporal
Accrual Periodicity:
Irregular
Start Date:
01 August 2016
Time Lag:
Variable
Accessibility
Access
Access Rights:
In progress
Delivery Lead Time:
Variable
Data Controller:
University of Nottingham
Data Processor:
Professor Guruprasad Aithal and Dr Jane Grove
Usage
Data Use Limitations:
General research use
Format and Standards
Vocabulary Encoding Schemes:
LOCAL
Conforms To:
OTHER
Languages:
en
Formats:
Database
Observations
Statistical Population
Population Description
Population Size
Measured Property
Observation Date
Persons
46
Count
01 August 2016